Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Lung Cancer

  Free Subscription


01.01.2018

2 AJR Am J Roentgenol
1 Am J Ind Med
8 Am J Respir Crit Care Med
4 Ann Oncol
6 Ann Thorac Surg
8 Anticancer Res
1 Arch Bronconeumol
1 BMC Cancer
1 BMJ
2 Cancer
1 Cancer Chemother Pharmacol
2 Cancer Lett
1 Cancer Sci
2 Chest
2 Clin Lung Cancer
1 Clin Nucl Med
2 Eur J Cardiothorac Surg
1 Eur Respir J
1 Genes Chromosomes Cancer
1 Int J Cancer
4 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Comput Assist Tomogr
2 J Nucl Med
3 J Thorac Cardiovasc Surg
10 J Thorac Oncol
2 Lancet Respir Med
6 Lung Cancer
1 Lung Cancer (Auckl)
1 Mol Carcinog
1 Oncol Rep
5 PLoS One
1 Semin Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LEE C
    Screening for Lung Cancer: Effective Recruitment Methods.
    AJR Am J Roentgenol. 2017 Dec 20:1-4. doi: 10.2214/AJR.17.18755.
    PubMed     Text format     Abstract available

  2. CARTER BW, Lichtenberger JP 3rd, Wu CC, Munden RF, et al
    Screening for Lung Cancer: Lexicon for Communicating With Health Care Providers.
    AJR Am J Roentgenol. 2017 Dec 20:1-7. doi: 10.2214/AJR.17.18865.
    PubMed     Text format     Abstract available


    Am J Ind Med

  3. BEN KHEDHER S, Neri M, Guida F, Matrat M, et al
    Occupational exposure to textile dust and lung cancer risk: Results from the ICARE Study.
    Am J Ind Med. 2017 Dec 27. doi: 10.1002/ajim.22799.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  4. MILLER R, Mudambi L, Vial MR, Kalhor N, et al
    Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.
    Am J Respir Crit Care Med. 2017;196:e10-e11.
    PubMed     Text format    

  5. SHANNON VR, Nanda AS, Middleton LP, Faiz SA, et al
    Pulmonary Mucinous Cystadenocarcinoma Presenting as Extensive Multifocal Cystic Lesions.
    Am J Respir Crit Care Med. 2017;195:1267-1268.
    PubMed     Text format    

  6. CIONE E, Gallelli L
    Direct Detection of Circulating MicroRNAs Unveiled the Absence of MicroRNA-218-5p in Smoker Subjects.
    Am J Respir Crit Care Med. 2017;196:532.
    PubMed     Text format    

  7. RADZIKOWSKA E, Blasinska-Przerwa K, Szolkowska M, Miasko A, et al
    Kaposiform Lymphangiomatosis with Human Papillomavirus Infection.
    Am J Respir Crit Care Med. 2017;195:e47-e48.
    PubMed     Text format    

  8. CHADDHA U, Hagen JA, Yaghmour B
    Pulmonary Rhabdomyosarcoma Associated with Check-Valve Mechanism.
    Am J Respir Crit Care Med. 2017;196:e7-e9.
    PubMed     Text format    

  9. KIM CH, Jeong JS, Kim SR, Choe YH, et al
    Coexistence of Mediastinal Castleman Disease with Spindle Cell Carcinoma of the Lung.
    Am J Respir Crit Care Med. 2017;196:652-654.
    PubMed     Text format    

  10. KORDE A, Jin L, Zhang JG, Ramaswamy A, et al
    Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.
    Am J Respir Crit Care Med. 2017;196:1443-1455.
    PubMed     Text format     Abstract available

  11. RAMPINELLI C, Spitaleri G, Passaro A, Pochesci A, et al
    Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer.
    Am J Respir Crit Care Med. 2017;196:1349-1350.
    PubMed     Text format    


    Ann Oncol

  12. CHANDRANI P, Prabhash K, Prasad R, Sethunath V, et al
    Drug-sensitive FGFR3 mutations in lung adenocarcinoma.
    Ann Oncol. 2017;28:597-603.
    PubMed     Text format     Abstract available

  13. KIM ST, Kim SY, Klempner SJ, Yoon J, et al
    Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
    Ann Oncol. 2017;28:547-554.
    PubMed     Text format     Abstract available

  14. YU HA, Sima C, Feldman D, Liu LL, et al
    Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers.
    Ann Oncol. 2017;28:278-284.
    PubMed     Text format     Abstract available

  15. YANG TO, Cairns BJ, Reeves GK, Green J, et al
    Cancer risk among 21st century blood transfusion recipients.
    Ann Oncol. 2017;28:393-399.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  16. BROWN LM, Cooke DT, Jett JR, David EA, et al
    Extent of Resection and Lymph Node Assessment for Clinical Stage T1aN0M0 Typical Carcinoid Tumors.
    Ann Thorac Surg. 2018;105:207-213.
    PubMed     Text format     Abstract available

  17. GOUDIE E, Oliveira RL, Thiffault V, Jouquan A, et al
    Phase 1 Trial Evaluating Safety of Pulmonary Artery Sealing With Ultrasonic Energy in VATS Lobectomy.
    Ann Thorac Surg. 2017 Nov 17. pii: S0003-4975(17)31112.
    PubMed     Text format     Abstract available

  18. CHEN T, Luo J, Gu H, Gu Y, et al
    Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma.
    Ann Thorac Surg. 2018;105:302-308.
    PubMed     Text format     Abstract available

  19. HARATAKE N, Toyokawa G, Takada K, Kozuma Y, et al
    Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung Cancer.
    Ann Thorac Surg. 2017 Dec 15. pii: S0003-4975(17)31269.
    PubMed     Text format     Abstract available

  20. YANG CJ, McSherry F, Mayne NR, Wang X, et al
    Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small-Cell Lung Cancer.
    Ann Thorac Surg. 2017 Dec 16. pii: S0003-4975(17)31276.
    PubMed     Text format     Abstract available

  21. GALETTA D, Spaggiari L
    Early and Long-Term Results of Tracheal Sleeve Pneumonectomy for Lung Cancer After Induction Therapy.
    Ann Thorac Surg. 2017 Dec 22. pii: S0003-4975(17)31630.
    PubMed     Text format     Abstract available


    Anticancer Res

  22. PRECIVAL C, Landy M, Poole C, Mullaney L, et al
    The Role of Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:7-14.
    PubMed     Text format     Abstract available

  23. DAMASKOS C, Tomos I, Garmpis N, Karakatsani A, et al
    Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
    Anticancer Res. 2018;38:37-43.
    PubMed     Text format     Abstract available

  24. FANG T, Huang H, Li X, Liao J, et al
    Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:179-186.
    PubMed     Text format     Abstract available

  25. SHEN TC, Chang WS, Tsai CW, Chao CY, et al
    The Contribution of Matrix Metalloproteinase-1 Promoter Genotypes in Taiwan Lung Cancer Risk.
    Anticancer Res. 2018;38:253-257.
    PubMed     Text format     Abstract available

  26. JUNG CY, Kim SY, Lee C
    Carvacrol Targets AXL to Inhibit Cell Proliferation and Migration in Non-small Cell Lung Cancer Cells.
    Anticancer Res. 2018;38:279-286.
    PubMed     Text format     Abstract available

  27. SLUGA R, VAN DEN Borne BEEM, Roepman P, Peters BJM, et al
    Utilization of Molecular Testing and Survival Outcomes of Treatment with First- or Second-line Tyrosine Kinase Inhibitors in Advanced Non-small Cell Lung Cancer in a Dutch Population.
    Anticancer Res. 2018;38:393-400.
    PubMed     Text format     Abstract available

  28. TAKAMORI S, Toyokawa G, Okamoto I, Takada K, et al
    Clinical Significance of PD-L1 Expression in Brain Metastases from Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:553-557.
    PubMed     Text format     Abstract available

  29. KATAOKA Y, Hirano K, Narabayashi T, Hara S, et al
    Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:559-563.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  30. DE VEGA SANCHEZ B, Lobato Astiarraga I, Lopez Castro R, Lopez Pedreira MR, et al
    Skeletal Muscle Metastasis: An Uncommon Finding in Lung Cancer.
    Arch Bronconeumol. 2017 Dec 22. pii: S0300-2896(17)30428.
    PubMed     Text format    


    BMC Cancer

  31. LIU D, Huang Y, Li L, Song J, et al
    High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer.
    BMC Cancer. 2017;17:882.
    PubMed     Text format     Abstract available


    BMJ

  32. BALDWIN DR, Ten Haaf K, Rawlinson J, Callister MEJ, et al
    Low dose CT screening for lung cancer.
    BMJ. 2017;359:j5742.
    PubMed     Text format    


    Cancer

  33. TANDBERG DJ, Tong BC, Ackerson BG, Kelsey CR, et al
    Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.
    Cancer. 2017 Dec 19. doi: 10.1002/cncr.31196.
    PubMed     Text format     Abstract available

  34. ARBOUR KC, Kris MG, Riely GJ, Ni A, et al
    Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
    Cancer. 2017 Sep 21. doi: 10.1002/cncr.30990.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  35. SATO J, Morikawa N, Chiba R, Nihei S, et al
    Case series on the association between blood levels and side effects of afatinib maleate.
    Cancer Chemother Pharmacol. 2017;80:545-553.
    PubMed     Text format     Abstract available


    Cancer Lett

  36. LEE JY, Talhi O, Jang D, Cerella C, et al
    Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer.
    Cancer Lett. 2017;416:94-108.
    PubMed     Text format     Abstract available

  37. CHAI S, Qian Y, Tang J, Liang Z, et al
    Retraction notice to "Ca2+/Calmodulin-dependent protein kinase IIgamma, a critical mediator of the NF-kappaB network, is a novel therapeutic target in non-small cell lung cancer" [Cancer Lett. 344(1) (2014) 119-128].
    Cancer Lett. 2018;414:312.
    PubMed     Text format    


    Cancer Sci

  38. CHENG HW, Chein RJ, Cheng TJ, Wu PS, et al
    The 2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction.
    Cancer Sci. 2017 Dec 29. doi: 10.1111/cas.13489.
    PubMed     Text format     Abstract available


    Chest

  39. MURGU S, Rabito R, Lasko G, Jackson C, et al
    Impact of a Non-Small Cell Lung Cancer Educational Program for Interdisciplinary Teams.
    Chest. 2017 Dec 12. pii: S0012-3692(17)33212-9. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available

  40. YANG CJ, Wang H, Kumar A, Wang X, et al
    Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma.
    Chest. 2017;152:1239-1250.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  41. MA SJ, Cummings M, Serra LM, Syed YA, et al
    Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis.
    Clin Lung Cancer. 2017 Nov 26. pii: S1525-7304(17)30319.
    PubMed     Text format     Abstract available

  42. STOY SP, Segal JP, Mueller J, Furtado LV, et al
    Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Dec 5. pii: S1525-7304(17)30322.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  43. SAMPAIO VIEIRA T, Borges Faria D, Azevedo Silva F, Pimentel F, et al
    The Impact of a Bayesian Penalized Likelihood Reconstruction Algorithm on the Evaluation of Indeterminate Pulmonary Nodules by Dual-Time Point 18F-FDG PET/CT.
    Clin Nucl Med. 2017 May 19. doi: 10.1097/RLU.0000000000001713.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  44. HINO H, Karasaki T, Yoshida Y, Fukami T, et al
    Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years.
    Eur J Cardiothorac Surg. 2017 Dec 18. pii: 4759172. doi: 10.1093.
    PubMed     Text format     Abstract available

  45. YENDAMURI S, Groman A, Miller A, Demmy T, et al
    Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 13. pii: 4740938. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Respir J

  46. DECALUWE H, Dooms C, D'Journo XB, Call S, et al
    Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    Genes Chromosomes Cancer

  47. LIU L, Liu H, Shao D, Liu Z, et al
    Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in non-small cell lung cancer.
    Genes Chromosomes Cancer. 2017 Dec 26. doi: 10.1002/gcc.22522.
    PubMed     Text format     Abstract available


    Int J Cancer

  48. DAI L, Smith CD, Foroozesh M, Miele L, et al
    The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31234.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  49. JETER MD, Gomez D, Nguyen QN, Komaki R, et al
    Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer:
    Int J Radiat Oncol Biol Phys. 2017 Nov 3. pii: S0360-3016(17)34055.
    PubMed     Text format     Abstract available

  50. KUMAR S, Feddock J, Li X, Shearer AJ, et al
    Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:652-659.
    PubMed     Text format     Abstract available

  51. OHRI N, Bodner WR, Kabarriti R, Shankar V, et al
    Positron Emission Tomography-Adjusted Intensity Modulated Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Oct 28. pii: S0360-3016(17)34039.
    PubMed     Text format     Abstract available

  52. YU W, Tang C, Hobbs BP, Li X, et al
    Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Nov 15. pii: S0360-3016(17)34061.
    PubMed     Text format     Abstract available


    J Clin Oncol

  53. OBEID R, Pietrzik K
    Smoking, B Vitamins, and Lung Cancer: The Chicken or the Egg Causality Dilemma.
    J Clin Oncol. 2017 Dec 28:JCO2017759472. doi: 10.1200/JCO.2017.75.9472.
    PubMed     Text format    


    J Comput Assist Tomogr

  54. KOCHER MR, Sharma A, Garrett-Mayer E, Ravenel JG, et al
    Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy.
    J Comput Assist Tomogr. 2017 Dec 14. doi: 10.1097/RCT.0000000000000653.
    PubMed     Text format     Abstract available


    J Nucl Med

  55. FLEDELIUS J, Winther-Larsen A, Khalil AA, Bylov CM, et al
    18F-FDG-PET/CT for very early response evaluation predicts CT response in Erlotinib treated NSCLC patients - A comparison of assessment methods.
    J Nucl Med. 2017 May 10. pii: jnumed.117.193003. doi: 10.2967/jnumed.117.193003.
    PubMed     Text format     Abstract available

  56. STEIGER S, Arvanitakis M, Sick B, Weder W, et al
    Analysis of prognostic values of various PET metrics in preoperative FDG PET for early stage bronchial carcinoma for progression free and overall survival: significantly increased glycolysis is a predictive factor.
    J Nucl Med. 2017 May 10. pii: jnumed.117.189894. doi: 10.2967/jnumed.117.189894.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  57. MOGHANAKI D, Simone CB 2nd, Rimner A, Karas TZ, et al
    The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:429-431.
    PubMed     Text format    

  58. DIGESU CS, Hachey KJ, Gilmore DM, Khullar OV, et al
    Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 13. pii: S0022-5223(17)32505.
    PubMed     Text format     Abstract available

  59. GELLER AD, Zheng H, Mathisen DJ, Wright CD, et al
    Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 20. pii: S0022-5223(17)32702.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  60. MCCANN B, Clark B
    Four-Year Complete Remission in a Patient with Metastatic Epidermal Growth Factor Receptor-Mutated Lung Cancer Treated with Two Cycles of Erlotinib.
    J Thorac Oncol. 2018;13:e7-e8.
    PubMed     Text format    

  61. ZHANG X, Zheng X
    Reply to "Obesity Paradox in Lung Cancer Prognosis: Is MiR-26b the Achilles Heel?"
    J Thorac Oncol. 2018;13:e16.
    PubMed     Text format    

  62. MORMILE R
    Obesity Paradox in Lung Cancer Prognosis: Is MiR-26b the Achilles Heel?
    J Thorac Oncol. 2018;13:e15.
    PubMed     Text format    

  63. FELIP E, Barlesi F, Besse B, Chu Q, et al
    Brief Report: Phase 2 Study of the HSP-90 inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer.
    J Thorac Oncol. 2017 Dec 13. pii: S1556-0864(17)33083.
    PubMed     Text format     Abstract available

  64. TSENG YH, Ho HL, Lai CR, Luo YH, et al
    Brief Report: PD-L1 expression of tumor cells, macrophages, and immune cells in non-small cell lung cancer patients with malignant pleural effusion.
    J Thorac Oncol. 2017 Dec 12. pii: S1556-0864(17)33079.
    PubMed     Text format     Abstract available

  65. AOKAGE K, Miyoshi T, Ishii G, Kusumoto M, et al
    Influence of Ground-Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
    J Thorac Oncol. 2017 Dec 12. pii: S1556-0864(17)33080.
    PubMed     Text format     Abstract available

  66. PILOTTO S, Sperduti I, Leuzzi G, Chiappetta M, et al
    Prognostic Model for Resected Squamous-Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment.
    J Thorac Oncol. 2017 Dec 18. pii: S1556-0864(17)33101.
    PubMed     Text format     Abstract available

  67. RICCIUTI B, Metro G, Brambilla M, Ludovini V, et al
    Acquired Resistance to Afatinib Due to T790M-Positive Squamous Progression in EGFR-Mutant Adenosquamous Lung Carcinoma.
    J Thorac Oncol. 2018;13:e9-e12.
    PubMed     Text format    

  68. ROBIN TP, Camidge DR, Stuhr K, Nath SK, et al
    Excellent Outcomes with Radiosurgery for Multiple Brain Metastases in Oncogene-Addicted Non-Small-Cell Lung Cancer.
    J Thorac Oncol. 2017 Dec 18. pii: S1556-0864(17)33107.
    PubMed     Text format     Abstract available

  69. WU SP, Liao RQ, Tu HY, Wang WJ, et al
    Stromal PD-L1+regulatory T cells and PD-1+CD8+ T cells define the response of different subsets of non-small-cell lung cancer to PD-1/PD-L1 blockade immunotherapy.
    J Thorac Oncol. 2017 Dec 18. pii: S1556-0864(17)33102.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  70. LIN CC, Shih JY, Yu CJ, Ho CC, et al
    Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study.
    Lancet Respir Med. 2017 Dec 14. pii: S2213-2600(17)30480.
    PubMed     Text format     Abstract available

  71. SUDA K
    DNA shedding in non-small-cell lung cancer: useful to assess?
    Lancet Respir Med. 2017 Dec 14. pii: S2213-2600(17)30479.
    PubMed     Text format    


    Lung Cancer

  72. DUDNIK E, Moskovitz M, Daher S, Shamai S, et al
    Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data.
    Lung Cancer. 2017 Nov 23. pii: S0169-5002(17)30582.
    PubMed     Text format     Abstract available

  73. METRO G, Tazza M, Matocci R, Chiari R, et al
    Optimal management of ALK-positive NSCLC progressing on crizotinib.
    Lung Cancer. 2017;106:58-66.
    PubMed     Text format     Abstract available

  74. BASLER L, Kroeze SG, Guckenberger M
    SBRT for oligoprogressive oncogene addicted NSCLC.
    Lung Cancer. 2017;106:50-57.
    PubMed     Text format     Abstract available

  75. VANDERLAAN PA, Rangachari D, Mockus SM, Spotlow V, et al
    Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes.
    Lung Cancer. 2017;106:17-21.
    PubMed     Text format     Abstract available

  76. KWON D, Koh J, Kim S, Go H, et al
    MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics.
    Lung Cancer. 2017;106:131-137.
    PubMed     Text format     Abstract available

  77. HONG SW, Park NS, Noh MH, Shim JA, et al
    Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway.
    Lung Cancer. 2017;106:115-124.
    PubMed     Text format     Abstract available


    Lung Cancer (Auckl)

  78. MINAMI S, Ogata Y, Ihara S, Yamamoto S, et al
    Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer.
    Lung Cancer (Auckl). 2017;8:249-257.
    PubMed     Text format     Abstract available


    Mol Carcinog

  79. WANG H, Wang L, Cao L, Zhang Q, et al
    Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
    Mol Carcinog. 2017 Dec 26. doi: 10.1002/mc.22777.
    PubMed     Text format     Abstract available


    Oncol Rep

  80. CHANG WA, Yen MC, Hung JY, Yang CJ, et al
    Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer.
    Oncol Rep. 2018;39:573-581.
    PubMed     Text format     Abstract available


    PLoS One

  81. HAN KN, Kim HK, Choi YH
    Midterm outcomes of single port thoracoscopic surgery for major pulmonary resection.
    PLoS One. 2017;12:e0186857.
    PubMed     Text format     Abstract available

  82. KANG G, Liu K, Hou B, Zhang N, et al
    3D multi-view convolutional neural networks for lung nodule classification.
    PLoS One. 2017;12:e0188290.
    PubMed     Text format     Abstract available

  83. OOI CC, Mantalas GL, Koh W, Neff NF, et al
    High-throughput full-length single-cell mRNA-seq of rare cells.
    PLoS One. 2017;12:e0188510.
    PubMed     Text format     Abstract available

  84. ZHANG H, Diao H, Jia L, Yuan Y, et al
    Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
    PLoS One. 2017;12:e0188960.
    PubMed     Text format     Abstract available

  85. KIM H, Park CM, Keam B, Park SJ, et al
    The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.
    PLoS One. 2017;12:e0187500.
    PubMed     Text format     Abstract available


    Semin Oncol

  86. TABCHI S, Kassouf E, Rassy EE, Kourie HR, et al
    Management of stage III non-small cell lung cancer.
    Semin Oncol. 2017;44:163-177.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: